Rights and permissions
About this article
Cite this article
Efavirenz-based therapy a winner for HIV-1 infections. Inpharma Wkly. 1556, 11–12 (2006). https://doi.org/10.2165/00128413-200615560-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615560-00026